Litcius/Paper detail

A direct thrombin inhibitor, dabigatran etexilate protects from renal fibrosis by inhibiting protease activated receptor-1

Mohd Aslam Saifi, Shivaraju Annaldas, Chandraiah Godugu

2020European Journal of Pharmacology18 citationsDOI

Topics & Concepts

Direct thrombin inhibitorThrombinMedicineKidneyFibrosisDabigatranRenal functionThrombin receptorKidney diseaseAcute kidney injuryInflammationDiscovery and development of direct thrombin inhibitorsPharmacologyCancer researchInternal medicineEndocrinologyUrologyPlateletWarfarinAtrial fibrillationBlood Coagulation and Thrombosis MechanismsAcute Kidney Injury ResearchHemophilia Treatment and Research
A direct thrombin inhibitor, dabigatran etexilate protects from renal fibrosis by inhibiting protease activated receptor-1 | Litcius